Contact Us

Yes, with viability considerations specific to UBE2C's essential function: • Construct design: use a codon-modified UBE2C sequence with a small C-terminal tag (FLAG, HA). UBE2C is small (~179 amino acids); the destruction box-like N-terminal motif should be preserved. • Catalytically-dead rescue: the C114A mutation in the active site abolishes ubiquitin transfer activity and is the standard specificity control. • Viability and timing: UBE2C is essential for mitotic exit — knockout cells may have limited viability, requiring rescue experiments to be initiated before terminal mitotic failure. Inducible knockout systems combined with rescue constructs are often preferred. • Functional readout: rescue should restore APC/C-mediated degradation of cyclin B1 and securin during mitotic exit, measured by cell cycle progression and substrate degradation kinetics. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on the experimental question. The Knockout line is appropriate for asking whether UBE2B (RAD6B) is required for its reported functions in DNA damage tolerance — particularly PCNA monoubiquitination during translesion synthesis — and chromatin-related ubiquitination events. Overexpression is useful for testing sufficiency or for distinguishing UBE2B from its RAD6A (UBE2A) paralog. For UBE2B research, the EDITGENE Knockout line in HAP1 provides a clean genetic background for dissecting UBE2B-specific functions. Note that UBE2A and UBE2B (RAD6A and RAD6B) have substantial functional overlap — comprehensive analysis often requires considering both paralogs. Rescue with wild-type or catalytically-dead UBE2B is the standard specificity control.

Yes. UBE2B rescue experiments require attention to RAD6A/B paralog biology and DNA damage timing: • Construct design: use a codon-modified UBE2B sequence with a small N- or C-terminal tag (FLAG, HA). UBE2B is small (~152 amino acids); both tag positions are typically tolerated. • Catalytically-dead rescue: the C88A mutation in the active site cysteine abolishes ubiquitin transfer activity and is the standard control. • RAD6A paralog considerations: UBE2A (RAD6A) shares >95% sequence identity with UBE2B (RAD6B) and has substantially overlapping functions — analyses should consider both paralogs to interpret single-knockout phenotypes. • Functional readout: rescue should restore PCNA monoubiquitination following UV damage and translesion synthesis-dependent damage tolerance. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on whether you are studying TUBB1's role in platelet biology or modeling TUBB1-associated thrombocytopenia. The Knockout line is the standard tool for both — TUBB1 mutations cause inherited macrothrombocytopenia, and TUBB1 KO recapitulates aspects of impaired proplatelet formation. Overexpression is useful for studying TUBB1 incorporation into microtubule networks in cells that do not normally express it. Note that TUBB1 expression is largely restricted to megakaryocytes and platelets in vivo — HAP1, like most non-megakaryocytic cell lines, expresses minimal endogenous TUBB1. The EDITGENE Knockout line is useful for studying TUBB1 in heterologous expression contexts or for confirming complete loss in cells with low baseline expression. Rescue with wild-type or disease-mutant TUBB1 (e.g., Q43P, R318W) is informative for inherited thrombocytopenia research.

Yes. TUBB1 rescue experiments require attention to tubulin assembly biology and tissue-specific expression: • Construct design: use a codon-modified TUBB1 sequence. Tubulins are highly sensitive to N-terminal modifications — C-terminal tags are strongly preferred, and small epitope tags (FLAG, HA, Myc) are recommended over larger fusion tags. • Disease mutation rescue: TUBB1 thrombocytopenia-associated mutations (Q43P, R318W, R215C) can be introduced for genotype-phenotype correlation studies in a controlled cellular background. • Heterologous expression context: HAP1 normally expresses minimal TUBB1 — rescue experiments effectively become heterologous expression studies, useful for assessing TUBB1 incorporation into microtubule networks. • Functional readout: rescue should restore TUBB1 incorporation into microtubules (immunofluorescence) and, where relevant, assembly characteristics distinct from other β-tubulin isotypes. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on whether you are studying TTBK2's role in ciliogenesis or modeling spinocerebellar ataxia type 11. The Knockout line is the standard tool for both — TTBK2 mutations cause SCA11 through impaired ciliogenesis, and TTBK2 KO recapitulates the cilia assembly defect. Overexpression is useful for testing whether elevated TTBK2 activity is sufficient to drive enhanced cilia formation or for in vitro kinase assays. For ciliogenesis research, the EDITGENE Knockout line in HAP1 is highly informative — TTBK2 functions at the distal centriole to initiate ciliogenesis, and its complete loss prevents cilia formation. Rescue with wild-type, kinase-dead, or SCA11 truncation-mutant TTBK2 is essential for distinguishing kinase activity from scaffolding functions and modeling disease genetics.

Yes. TTBK2 rescue experiments require attention to kinase activity and centriolar targeting: • Construct design: use a codon-modified TTBK2 sequence with a C-terminal tag (FLAG, HA). TTBK2 is a large kinase (~1,244 amino acids); full-length cloning requires careful vector selection. • Kinase-dead rescue: the D163A mutation abolishes kinase activity and is the standard specificity control for distinguishing catalytic from scaffolding functions in ciliogenesis. • SCA11 truncation rescue: SCA11-associated truncation mutants (typically C-terminal truncations) can be introduced to study dominant-negative or haploinsufficiency mechanisms. • Functional readout: rescue should restore primary cilia formation (Arl13b/acetylated tubulin staining) and CP110 removal from the mother centriole. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on the experimental question. The Knockout line is appropriate for asking whether TSSK4 is required for its proposed roles in spermatogenesis and male fertility — though TSSK4 functions are still being characterized. Overexpression is useful for testing kinase activity in vitro or for studying TSSK4 in heterologous systems. For TSSK4 research, an important caveat is that TSSK4 is normally expressed in male germ cells, particularly testis-specific contexts — HAP1, like most somatic cell lines, expresses minimal endogenous TSSK4. The EDITGENE Knockout line is useful for confirming complete loss in cells with low baseline expression or for in vitro biochemical studies. For physiological TSSK4 functional studies, germ cell-specific models or transgenic systems are typically more appropriate.

Yes, with important context-related caveats: • Construct design: use a codon-modified TSSK4 sequence with a small C-terminal tag (FLAG, HA). TSSK4 is relatively small; both tag positions can be tested. • Kinase-dead rescue: an active site mutation (typically targeting the conserved DFG motif lysine) serves as the catalytic activity specificity control. • Heterologous expression context: HAP1 does not normally express TSSK4 — rescue experiments effectively assess TSSK4 function in a heterologous somatic background, which may not recapitulate testis-specific protein interactions. • Functional readout: rescue should restore TSSK4 kinase activity on candidate substrates identified by in vitro phosphorylation or phosphoproteomics in heterologous expression contexts. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on the experimental question. The Knockout line is appropriate for asking whether TSSK2 is required for its reported roles in spermiogenesis, chromatin remodeling during sperm maturation, or — emerging — its non-germline functions. Overexpression is useful for studying TSSK2 kinase activity in vitro or in heterologous systems. Similar to TSSK4, TSSK2 expression is largely testis-specific, so the EDITGENE Knockout in HAP1 is most useful for in vitro biochemistry, kinase substrate identification, or heterologous expression studies rather than physiological spermatogenesis research. Rescue with wild-type or kinase-dead TSSK2 is the standard control for assigning observed effects to catalytic activity.

Yes, with similar context considerations to TSSK4: • Construct design: use a codon-modified TSSK2 sequence with a small C-terminal tag (FLAG, HA). • Kinase-dead rescue: an active site mutation (DFG motif lysine or conserved aspartate) abolishes kinase activity and is the standard specificity control. • Heterologous expression context: HAP1 expresses minimal endogenous TSSK2 — rescue assesses TSSK2 function in a non-physiological context. Physiological substrate engagement may differ from testis-specific contexts. • Functional readout: rescue should restore TSSK2 kinase activity on substrates identified by in vitro or heterologous phosphoproteomics. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on whether you are studying TSPO's role in mitochondrial cholesterol transport, steroidogenesis, or its widely-used function as a neuroinflammation biomarker. The Knockout line is the standard tool for asking whether TSPO is required for these processes — particularly relevant given that conditional TSPO KO mouse studies have raised questions about the magnitude of its in vivo functional requirements. Overexpression is useful for testing whether elevated TSPO drives enhanced cholesterol transport or for studying TSPO ligand binding. For TSPO research, the EDITGENE Knockout line in HAP1 provides a clean genetic background for dissecting cellular TSPO functions. Rescue with wild-type or pharmacologically modified TSPO ligand-binding mutants is particularly valuable given the extensive use of TSPO-targeting PET tracers and the need to distinguish on-target from off-target ligand effects.

Yes. TSPO rescue experiments require attention to mitochondrial outer membrane targeting and ligand binding: • Construct design: use a codon-modified TSPO sequence with a C-terminal tag (FLAG, HA). TSPO is a small (169 amino acids) mitochondrial outer membrane protein with five transmembrane domains — N-terminal tags can interfere with mitochondrial targeting. • Ligand-binding mutant rescue: specific mutations affecting cholesterol binding or pharmacological ligand binding (e.g., A147T variant) can be introduced to dissect TSPO's distinct functional modes. • Mitochondrial localization validation: confirm mitochondrial outer membrane localization of exogenous TSPO by immunofluorescence co-staining with TOM20 before functional assays. • Inhibitor/ligand specificity controls: rescue is particularly valuable for confirming on-target effects of TSPO-targeting compounds (PK-11195, PBR28). HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on whether you are studying TSHR's role in thyroid signaling, modeling thyroid disease, or investigating its non-canonical expression in multiple myeloma. The Knockout line is the standard tool for these questions — particularly for studying TSHR signaling consequences in the MOLP-8 multiple myeloma context where TSHR has been reported with non-thyroid functions. Overexpression is useful for studying disease-associated activating mutations or for ligand-binding studies. Important context: TSHR is a major GPCR drug target, and MOLP-8 is a multiple myeloma cell line — the choice of MOLP-8 as the host suggests focus on TSHR's non-thyroid functions in hematological malignancies rather than classical thyroid biology. Rescue with wild-type, constitutively active (e.g., D633Y), or inactivating mutant TSHR is particularly informative for distinguishing constitutive from ligand-induced functions.

Yes. TSHR rescue experiments are well-established as a GPCR rescue system: • Construct design: use a codon-modified TSHR sequence with a C-terminal tag (FLAG, HA). TSHR is a seven-transmembrane GPCR — N-terminal tags after the signal peptide are tolerated, but the large extracellular ligand-binding domain (residues 1-415) must be preserved. • Disease mutation rescue: activating mutations (constitutively active TSHR like D633Y) and inactivating mutations can be introduced to model hyperthyroidism and hypothyroidism in the controlled cellular background. • Functional readout: rescue should restore TSH-stimulated cAMP production (measured by cAMP reporter assays or biochemical cAMP quantification). • MOLP-8 context: in the multiple myeloma background, rescue should additionally consider the non-canonical TSHR functions that have been reported in this cellular context. MOLP-8 is a suspension multiple myeloma cell line — transduction typically uses spinoculation-enhanced lentiviral delivery; expect lower transduction efficiency than adherent lines.